Tricida Inc.: Targeting Metabolic Acidosis In CKD Patients
Seeking Alpha,
Tricida will submit an NDA for TRC101 in metabolic acidosis in CKD patients this year.
Tricida will submit an NDA for TRC101 in metabolic acidosis in CKD patients this year.
This story was originally published by ProPublica. It was co-published with The New York Times.
One is dean of Yale's medical school. Another is the director of a cancer center in Texas.
The dean of Yale's medical school, the incoming president of a prominent cancer group and the head of a Texas cancer center are…